JINGHUA PHARM released its 2024 annual performance, with a net profit attributable to the parent company of 213 million yuan, a year-on-year decrease of 14.15%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, JINGHUA PHARM (002349.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.402 billion yuan, a year-on-year decrease of 7.25%. The net profit attributable to shareholders of the listed company was 213 million yuan, a year-on-year decrease of 14.15%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 196 million yuan, a year-on-year decrease of 17.43%. The basic earnings per share were 0.2612 yuan. It is proposed to distribute a cash dividend of 0.8 yuan (including tax) for every 10 shares to all shareholders
